#JPM22 goes vir­tu­al, cav­ing to pres­sure af­ter a wave of big drug­mak­ers pull out due to Omi­cron fears

Well, see you in Jan­u­ary 2023.

In a sur­prise about-face, #JPM22 will now be ful­ly vir­tu­al af­ter or­ga­niz­ers of the pop­u­lar biotech con­fer­ence de­cid­ed to pull the plug on a live event in San Fran­cis­co giv­en fears over the Omi­cron vari­ant and a grow­ing cho­rus of drug­mak­ers opt­ing out.

The move is no big sur­prise af­ter re­ports swirled about some of the in­dus­try’s biggest play­ers nix­ing plans to at­tend live and pres­sur­ing the bank to re­con­sid­er the an­nu­al meet at the West­in St. Fran­cis. STAT re­port­ed Tues­day that Mod­er­na and Am­gen, among oth­er large drug­mak­ers, had al­ready pulled out.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER